# CellulaREvolution

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellularevolution

- Industry: Biotechnology
- Headquarters: Newcastle upon Tyne, UK
- Website: www.cellularevolution.co.uk
- Total disclosed funding: $1.4M
- Latest round: Seed (Feb 16, 2021)
- Investors on record: 4

## About

Based in the UK, CellulaREvolution Limited develops advanced bioreactor technologies to improve operational efficiency in various sectors, focusing on innovative solutions that meet industry-specific needs.Founded in 2018, CellulaREvolution Limited operates out of Newcastle upon Tyne, UK, specializing in bioreactor technologies. The company has completed three funding rounds, with the latest round occurring on February 18, 2022, raising GBP 1.75 million led by Happiness Capital and participated by Allusion One. The founders are Che Connon and Martina Miotto, with Chris Green serving as CEO.CellulaREvolution Limited specializes in delivering innovative technology solutions designed to enhance operational efficiency across various industries. Their core product offerings include a comprehensive suite of software tools that facilitate data management, analytics, and process optimization. These tools are tailored to meet the needs of sectors such as healthcare, finance, and logistics, addressing challenges like real-time data access, compliance, and resource allocation. The company's solutions have been deployed in key geographical markets, including North America, Europe, and Asia-Pacific, showcasing their commitment to servicing a diverse clientele that ranges from small enterprises to large multinational corporations. By focusing on user-centric design and robust functionality, the company's products enable clients to streamline their operations while improving overall productivity and decision-making capabilities.The company's revenue generation model is rooted in a combination of subscription-based services and direct sales to businesses. Clients engage with the company through structured agreements that often involve annual or multi-year subscriptions for access to their flagship software products, which include advanced analytics platforms and data integration tools. In typical transactions, clients pay upfront for the annual subscription, granting them access to regular software updates, customer support, and training resources. The pricing structure is designed to cater to different business sizes, ensuring that various tiers of service are available to accommodate both small businesses and large enterprises. Additionally, the company may establish partnerships with other technology providers to enhance their service offerings, contributing to a diverse revenue stream while ensuring clients receive comprehensive solutions tailored to their needs.In February 2022, CellulaREvolution Limited raised GBP 1.75 million in venture funding, led by Happiness Capital, to accelerate research and development and boost its commercial team as it prepares to take its bioreactor technologies to market. The company plans to launch new product offerings designed to enhance their bioreactor technology in the upcoming year and aims to expand into North America and Asia-Pacific markets by the end of 2023.

## Funding rounds

- Seed, Feb 16, 2021, $1.4M — Northstar Ventures, CPT Capital, Orange Light Ventures
- Seed, Sep 12, 2019 — Northstar Ventures, Innovate UK

## Investors

- Northstar Ventures (https://capitalatlas.ai/funds/northstar-ventures) — Seed
- Innovate UK — Seed
- CPT Capital — Seed
- Orange Light Ventures — Seed